Details

Razvoj kakovosti predšolskega varstva v Občini Izola : diplomsko delo visokošolskega programa
ID Zrinski, Gregor (Author), ID Pečar, Zdravko (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (1,34 MB)
MD5: B367ED6C1C7DB893191E59CA447B5816
PID: 20.500.12556/rul/68337063-bc7f-48c9-a5ad-84c6e8c2672f

Language:Slovenian
Keywords:predšolska vzgoja, predšolsko varstvo, vrtec, Izola, diplomske naloge
Work type:Undergraduate thesis
Typology:2.11 - Undergraduate Thesis
Organization:FU - Faculty of Administration
Place of publishing:Ljubljana
Publisher:[G. Zrinski]
Year:2010
Number of pages:VIII, 42 str.
PID:20.500.12556/RUL-21615 This link opens in a new window
UDC:373.2(043.2)
COBISS.SI-ID:3559086 This link opens in a new window
Publication date in RUL:11.07.2014
Views:5278
Downloads:243
Metadata:XML DC-XML DC-RDF
:
ZRINSKI, Gregor, 2010, Razvoj kakovosti predšolskega varstva v Občini Izola : diplomsko delo visokošolskega programa [online]. Bachelor’s thesis. Ljubljana : G. Zrinski. [Accessed 27 March 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=21615
Copy citation
Share:Bookmark and Share

Similar documents

Similar works from RUL:
  1. Pomen tumorskih matičnih celic in epitelno-mezenhimskega prehoda pri napredovanju nedrobnoceličnega raka pljuč
  2. Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
  3. Proučevanje izražanja gena za fosfatidiletanolamin-N-metiltransferazo v nedrobnoceličnem pljučnem rakavem tkivu
  4. Uporabnost imunohistokemičnega določanja mutacij receptorja za epidermalni rastni faktor pri raku pljuč
  5. Sladkorna bolezen in športna vadba
Similar works from other Slovenian collections:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Back